Connect with us
Advertisement

Nigeria News

Madagascar Demands N78 Million From Nigeria For Coronavirus Herbal Remedy

Published

on

Madagascar Demands N78 Million From Nigeria For Coronavirus Herbal Remedy
Advertisement

The Republic of Madagascar has demanded that Nigeria pay N78.2 Million for the amount of its Coronavirus Herbal Remedy sent to the Federal Government.

Naija News had reported earlier that President Muhammadu Buhari received the Madagascar Coronavirus Herbal Remedy over the weekend from Guinea Bissau President Umaro Sissoco Embalo, who visited the President at the State House in Abuja, Nigeria’s capital.

A source familiar with the demand from Madagascar for its Coronavirus cure said: “For our transfers in Guinea Bissau, Madagascar has requested that Nigeria pay over €170,000 (N78, 200,000). We have gotten the receipt in light of the fact that the African nation has made us to understand that the medications are not being given out free. – A source said on Sunday

Advertisement

“We are being approached to pay for the medications yet to be approved. Since the AU guided the gracefully of the medications to African nations, we may have no way out than to pay for it.

“This installment may, be that as it may, be one-off on the grounds that mass importation of the medications from Madagascar won’t be financially savvy. When we consider the expense of cargo, the sum will be excessively high.

“This is the reason we are taking a gander at nearby alternatives accessible to us as a country.

Advertisement

“A few scientists have disclosed to us that we have more extravagant herbs to contain COVID-19. Truth be told, a shop in Wuse 2, Abuja has been found to sell Artemisia Tea with high intensity than COV drugs.

“As a country, we will leave all choices open and look inwards. In any case, we will expose Madagascar home grown medications to confirmation or approval.

“The Presidential Task Force (PTF) on COVID-19 is additionally considering approaching the National Agency for Food and Drug Administration and Control (NAFDAC) and the National Institute for Pharmaceutical Research and Development (NIPRD) to loosen up the conventions and hurry the approval of nearby medications for COVID-19,” the source added.

Advertisement
Advertisement